Skip to content

Patient Management During Major Abdominal Surgery: an Oxygen Consumption Protocol Compared to Standard Approach

Patient Management During Major Abdominal Surgery: the Impact of a Hemodynamic Approach Oriented to Oxygen Consumption Optimization Compared to Standard Approach Targeting Preload-dependency and a Clinically-guided Strategy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03113435
Acronym
HEART-CORE
Enrollment
76
Registered
2017-04-13
Start date
2018-06-01
Completion date
2026-12-31
Last updated
2025-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic Instability

Keywords

CO2 gap, oxygen consumption, Stroke volume optimization

Brief summary

This study compares the actual standard of care with a new protocol to guide hemodynamic optimization during major abdominal surgery, which is more tailored on patient real needs. During general anesthesia metabolic needs of the body are markedly reduced and increase in CO may not be necessary. In addition, excessive fluid administration has been related to worse post-operative outcomes. We divide patients into three groups: the standard treatment group, the NICE protocol group and the intervention group. In this group we use the v-aCO2/CaO2-CvO2 as marker of tissue ability to increase their oxygen consumption in response to increased O2 delivery, and based on this index the administration of fluid. The principal aim is to optimize functional hemodynamics in order to reduce the fluid balance at the end of the surgery.

Interventions

OTHEROxygen consumption optimization

hemodynamic stability will be achieved through exploration of oxygen consumption need of the patient based on CO2gap/CaO2-CvO2 ratio

Sponsors

Flavia Torrini
CollaboratorUNKNOWN
Alessandra Bisanti
CollaboratorUNKNOWN
Eleonora Filipponi
CollaboratorUNKNOWN
Domenica Luca Grieco
CollaboratorUNKNOWN
Massimo Antonelli
CollaboratorUNKNOWN
Liliana Sollazzi
CollaboratorUNKNOWN
Valter Perilli
CollaboratorUNKNOWN
Andrea Russo
CollaboratorUNKNOWN
Pierpaolo Ciocchetti
CollaboratorUNKNOWN
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients aged \> 18 years * acquisition of written informed consent * Major abdominal surgery (major gastrointestinal surgery: DCP, gastrectomy, Miles, emicolectomy; gynecologic surgery: oncologic surgery) Surgery times ≥ 3 hours

Exclusion criteria

* Absolute contraindication to CVC placement * pregnant women * hepatic surgery * laparoscopic surgery * Major vascular surgery * Dialysis treatment and kidney transplant surgery * Severe heart failure (EF ≤ 35%) * Emergency surgery

Design outcomes

Primary

MeasureTime frameDescription
Perioperative fluid balancesurgeryPerioperative fluid balance

Secondary

MeasureTime frameDescription
Survival at 28 days28 days after surgeryPatients who survived at 28 days
Survival at hospital discharge1 day (Hospital discharge)Patient who survived at hospital discharge
Post-operative complication1 day (Hospital discharge)Increase in TnI, need for mechanical ventilation, infection, ICU admission, anastomotic leak, bleeding, AKI

Countries

Italy

Contacts

Primary ContactAntonio M Dell'Anna, MD
anthosdel@yahoo.it+390630154490

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026